This site has been produced by Kite, a Gilead Company

Terms of use

The following Terms of Use govern and apply to your use and/or reliance upon the CAR-T website ( which is funded and maintained by Gilead Sciences Ltd (“Gilead“). Gilead is a limited company registered in England and Wales (company number: 02543818). Our registered office address in Ireland is IDA Business & Technology Park, Carrigtohill, Co. Cork, Ireland.

Access and/or use of this Gilead website are subject to the terms and conditions set forth herein and all applicable laws, statutes, and/or regulations. If you do not agree to these terms, you must not use our site.

Gilead may revise these Terms of Use from time to time without further notice by updating this page.

Your access or use of this websiteindicates your acceptance of these Terms of Use, and your representation that you are at least eighteen (18) years of age.

Our site is directed to people residing in the United Kingdom and Ireland. We do not represent that content available on or through our site is appropriate for use or available in other locations.

Disclaimer of Warranties and Limitation of Liability


Nothing in these Terms of Use excludes or limits our liability to the extent that the same may not be excluded or limited as a matter of law, including (to such extent) liability for death or personal injury arising from our negligence, or our fraud or fraudulent misrepresentation.

Gilead will use reasonable efforts to include accurate and up-to-date information on this Gilead website, but all information is provided “AS IS.” Gilead makes no warranties or representations as to the accuracy of information presented on this Gilead website and disclaims all warranties, conditions or representations, express or implied, including any warranties of merchantability, fitness for a particular purpose, and non-infringement to the fullest extent permitted by applicable law which may apply to the Website and any content on it.

In addition, any information presented on this Gilead website as of a particular date may only be accurate as of such date and Gilead disclaims any responsibility to update such information. Gilead shall not be held responsible for any action taken that is based on the information presented on this Gilead website, and all users of this Gilead website agree that all access and use of this Gilead website, and any and all content presented on this Gilead website, is at the user’s own risk.

We do not guarantee that our site, or any content on it, will always be available or be uninterrupted. We may suspend or withdraw or restrict the availability of all or any part of our site for business and operational reasons.

Neither Gilead nor any of its agents or affiliates shall be liable for any direct, incidental, consequential, indirect, or punitive damages arising out of user’s access, use, or inability to use this Gilead website, use of or reliance on any content displayed on the Website or any errors or omissions in such content of this Gilead website.

Any communication or material you transmit to Gilead via this Gilead website or Internet electronic mail is transmitted by you on a non-confidential basis. Gilead makes no promise, express or implied, not to use such communication or material for any purpose whatsoever, including reproduction, publication, broadcast and posting.

Health Information

This Gilead website does not, and is not intended to, provide medical advice, nor does it provide instruction on the appropriate use of any product produced or supplied by Gilead, its affiliates, related companies, or its licensors or joint venture partners.

The information presented on this Gilead website should not be interpreted or construed in any way as a replacement or substitution for medical advice provided by a doctor or healthcare provider. It is important that you discuss your treatment options and any questions that you may have with your doctor or healthcare provider.

News & Press Releases

This Gilead website may contain information (including without limitation videos, abstracts, publications, postings, news and/or press releases), the content of which is accurate or current only as of the date of the particular information, video, abstract, publication, posting, news and/or press release, or posting. Gilead does not update press releases once they have been made public.

Intellectual Property: Copyrights &Trade Marks

The Gilead company name and logo, and all product names, regardless of whether or not they appear in large print or with a trademark symbol, are trademarks of Gilead, its affiliates, related companies, or its licensors or joint venture partners, unless otherwise noted. Use, reproduction, copying, or redistribution of these trade marks, without the written permission of Gilead is prohibited.

The entire content of this Gilead website, including any images or text, is protected by copyright. In consideration for your agreement to these Terms of Use, Gilead grants you a personal, non-exclusive, non-transferable licence to access and use this Gilead website. You may download material from this Gilead website only for personal, non-commercial use, and this Gilead website may not be copied, distributed, downloaded, modified, reused, reposted, or otherwise exploited except as provided herein without the express written permission of Gilead. It is the policy of Gilead to enforce its intellectual property rights to the fullest extent permitted under law. The use or misuse of these trade marks, copyrights, or other materials, except as permitted herein, is expressly prohibited and may be in violation of copyright law, trade mark law, communications regulations and statutes, and other laws, statutes, and/or regulations.

Third Party Websites

Gilead’s websites may include hyperlinks to websites maintained or controlled by others. Gilead is not responsible for and does not routinely screen, approve, review or endorse the contents of or use of any of the products or services that may be offered at these websites. Such websites are accessed at the users’ own risk.

How to Contact Us:

Postal address:

Gilead Sciences Ltd
280 High Holborn

Gilead Sciences
IDA Business & Technology Park
Co. Cork


If you would like to speak with someone in person, please contact the Public Affairs department at Gilead on +44 (0)20 3681 4500.

Last Updated: March 2023

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.

United Kingdom: Reporting of side effects

For patients residing in the United Kingdom, you can also report side effects directly via the Yellow Card Scheme at By reporting side effects, you can help provide more information on the safety of your medicine.

Republic of Ireland: Reporting of side effects

For patients residing in the Republic of Ireland, you can also report side effects directly via the HPRA website at By reporting side effects, you can help provide more information on the safety of your medicine.

This site is a patient information resource, intended only for patients residing in the United Kingdom and Ireland who are being referred for or have been prescribed CAR T-cell therapy by their healthcare professional. This site has been developed and paid for by Kite, a Gilead Company.

This site has been produced by Kite, a Gilead Company

© 2023 Gilead Sciences, Inc. All rights reserved. KITE and the Kite logo are registered trademarks of Kite Pharma, Inc | GILEAD is a registered trademark of Gilead Sciences, Inc and its related companies

UK-UNB-3792 April 2023